Psychiatry · San Rafael, CA
NPI
1295819274
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
99 Montecillo Rd
San Rafael, CA, 94903
Phone (415) 444-2000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$115K
3,731 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Joseph N Winer prescribed most often to Medicare patients was Lorazepam, with 438 prescriptions and refills. In total Joseph N Winer wrote 3,731 Medicare prescriptions that cost $115K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-06.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lorazepam Generic | 438 | 438 | 75 | $6,400 |
| Gabapentin Generic | 287 | 552 | 74 | $5,432 |
| Clonazepam Generic | 277 | 277 | 43 | $2,968 |
| Escitalopram Oxalate Generic | 212 | 626 | 66 | $2,801 |
| Trazodone Hcl Generic | 162 | 416 | 54 | $2,843 |
| Fluoxetine Hcl Generic | 145 | 415 | 46 | $1,971 |
| Bupropion Xl Bupropion Hcl | 142 | 366 | 42 | $3,450 |
| Diazepam Generic | 141 | 141 | 24 | $923 |
| Citalopram Hbr Citalopram Hydrobromide | 135 | 382 | 38 | $1,577 |
| Zolpidem Tartrate Generic | 133 | 133 | 21 | $920 |
| Temazepam Generic | 131 | 131 | 14 | $2,639 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 128 | 128 | 25 | $4,105 |
| Bupropion Hcl Sr Bupropion Hcl | 101 | 331 | 34 | $2,924 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 98 | 98 | 18 | $2,423 |
| Sertraline Hcl Generic | 94 | 280 | 34 | $1,418 |
Brand drugs: 94 claims; generic drugs: 3,637 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Joseph N Winer were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.